Max Fehlmann
President at CQDM - Enabling Drug Discovery/Accélérer la découverte du médicament - Montreal, QC, CA
Max Fehlmann's Colleagues at CQDM - Enabling Drug Discovery/Accélérer la découverte du médicament
Flore Oudouhou
Gestionnaire de Programme, Fonds dâaccélération des collaborations en santé
Max Fehlmann's Contact Details
514-766-6661
Montreal,Quebec,Canada
CQDM - Enabling Drug Discovery/Accélérer la découverte du médicament
Max Fehlmann's Company Details
CQDM - Enabling Drug Discovery/Accélérer la découverte du médicament
Montreal, QC, CA • 20 - 49 EmployeesMajor Drugs
Nous accélérons la découverte du médicament !CQDM is a pharma-based consortium active in biopharmaceutical research whose mission is to fund the development of innovative tools and technologies to accelerate drug discovery. Unique in the world, CQDM's business model is based on a collaborative approach where all stakeholders share the costs of biopharmaceutical research and benefit from its results. CQDM also provides a common meeting ground where academia, governments, biotechs and the pharmaceutical industry converge to address numerous complex medical challenges. CQDM receives financial support from Merck, Pfizer Inc., AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Eli Lilly Canada, Janssen, Novartis Pharma Canada, Sanofi Canada, as well as from Quebec's Ministry of Economy, Science and Innovation (MESI) and from the Government of Canada under the Business-Led Networks of Centres of Excellence Program (BL-NCE). For more information: www.cqdm.org.